Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


15.10.2018

19 AIDS
2 AIDS Res Hum Retroviruses
1 Am J Epidemiol
3 Clin Infect Dis
1 HIV Med
5 J Acquir Immune Defic Syndr
1 J Immunol
8 J Infect Dis
4 J Virol
2 Lancet
5 Lancet HIV
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nature
1 Pediatr Infect Dis J
1 PLoS Med
16 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
6 Science
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. ABRAMS EJ, Langwenya N, Gachuhi A, Zerbe A, et al
    Impact of universal ART for pregnant and postpartum women on ART uptake and retention.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002027.
    PubMed     Text format     Abstract available

  2. FORD ES, Magaret AS, Spak CW, Selke S, et al
    Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002002.
    PubMed     Text format     Abstract available

  3. SABIN CA, Harding R, Bagkeris E, Nkhoma K, et al
    Pain in people living with HIV and its association with healthcare resource use, well-being and functional status.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002021.
    PubMed     Text format     Abstract available

  4. MARUTHAMUTHU S, Raja R, Pandian K, Madasamy S, et al
    Inhibitory NK cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002028.
    PubMed     Text format     Abstract available

  5. CHOWDHURY FZ, Ouyang Z, Buzon M, Walker BD, et al
    Metabolic pathway activation distinguish transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002007.
    PubMed     Text format     Abstract available

  6. VOURLI G, Pharris A, Cazein F, Costagliola D, et al
    Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002034.
    PubMed     Text format     Abstract available

  7. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
    PubMed     Text format     Abstract available

  8. SUNDERMANN EE, Heaton RK, Pasipanodya E, Moore RC, et al
    Sex differences in HIV-associated cognitive impairment: an observational cohort study.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002012.
    PubMed     Text format     Abstract available

  9. NYAMATHI AM, Carpenter CL, Ekstrand ML, Yadav K, et al
    Randomized controlled trial of a community-based intervention on HIV and nutritional outcomes at six months among women living with HIV/AIDS in Rural India.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002016.
    PubMed     Text format     Abstract available

  10. LOHMANN S, White BX, Zuo Z, Chan MS, et al
    HIV messaging on twitter: an analysis of current practice and data-driven recommendations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002018.
    PubMed     Text format     Abstract available

  11. DEBEAUDRAP P, Bodeau-Livinec F, Pasquier E, Germanaud D, et al
    Neurodevelopmental outcomes in HIV-infected and uninfected African children aged 4 to 9 years from the pediacam cohort.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002023.
    PubMed     Text format     Abstract available

  12. ERICKSON M, Shannon K, Sernick A, Pick N, et al
    Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002036.
    PubMed     Text format     Abstract available

  13. GALAVIZ KI, Schneider MF, Tien P, Mehta CC, et al
    Predicting diabetes risk among HIV-positive and HIV-negative women: an assessment of the ADA and FINRISC diabetes risk scores.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002017.
    PubMed     Text format     Abstract available

  14. STONER MCD, Nguyen N, Kilburn K, Gomez-Olive FX, et al
    Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa: An HPTN 068 analysis.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002037.
    PubMed     Text format     Abstract available

  15. MAJONGA ED, Rehman AM, Simms V, Mchugh G, et al
    High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002031.
    PubMed     Text format     Abstract available

  16. SUDFELD CR, Buchanan A, Ulenga N, Spiegelman D, et al
    Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002033.
    PubMed     Text format     Abstract available

  17. LAUT KG, Shepherd L, Gottfredsson M, Sedlacek D, et al
    Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002035.
    PubMed     Text format     Abstract available

  18. ROUL H, Mary-Krause M, Ghosn J, Delaugerre C, et al
    CD4 cell count recovery after combined antiretroviral therapy in the modern cART era.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002010.
    PubMed     Text format     Abstract available

  19. MCMILLAN J, Szlachetka A, Zhou T, Morsey B, et al
    Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002032.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  20. PAYNE H, Chain G, Adams S, Hunter P, et al
    Naive B-cell output in HIV-infected and HIV-uninfected children.
    AIDS Res Hum Retroviruses. 2018 Oct 9. doi: 10.1089/AID.2018.0170.
    PubMed     Text format     Abstract available

  21. CURTIS AD, Walter K, Nabi R, Jensen K, et al
    Oral co-administration of an intramuscular DNA/ Modified Vaccinia Ankara vaccine for simian immunodeficiency virus is associated with better control of infection in orally exposed infant macaques.
    AIDS Res Hum Retroviruses. 2018 Oct 10. doi: 10.1089/AID.2018.0180.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  22. JENNESS SM, Maloney KM, Smith DK, Hoover KW, et al
    Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
    Am J Epidemiol. 2018 Oct 11. pii: 5127085. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  23. LIU AY, Zhang J, Anderson PL, Wagner T, et al
    Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
    Clin Infect Dis. 2018 Oct 4. pii: 5115666. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. HOESLEY CJ, Chen BA, Anderson PL, Dezzutti CS, et al
    Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings.
    Clin Infect Dis. 2018 Oct 4. pii: 5115615. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. CHEN BA, Zhang J, Gundacker HM, Hendrix CW, et al
    Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.
    Clin Infect Dis. 2018 Oct 4. pii: 5115671. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  26. CHEN J, Zhang R, Shen Y, Liu L, et al
    Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    HIV Med. 2018 Oct 12. doi: 10.1111/hiv.12679.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  27. MAZHNAYA A, Marcus R, Bojko MJ, Zelenev A, et al
    Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
    J Acquir Immune Defic Syndr. 2018;79:288-295.
    PubMed     Text format     Abstract available

  28. LEE WK, Milloy MJS, Nosova E, Walsh J, et al
    Predictors of antiretroviral adherence self-efficacy among people living with HIV/AIDS in a Canadian setting.
    J Acquir Immune Defic Syndr. 2018 Oct 5. doi: 10.1097/QAI.0000000000001878.
    PubMed     Text format     Abstract available

  29. WANG R, Shlipak MG, Ix JH, Brown TT, et al
    The Association of Fibroblast Growth Factor-23 (FGF-23) with Incident Frailty in HIV-Infected and -Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001868.
    PubMed     Text format     Abstract available

  30. ROBERTSON MM, Penrose K, Irvine MK, Robbins RS, et al
    Impact of an HIV Care Coordination Program on Durable Viral Suppression.
    J Acquir Immune Defic Syndr. 2018 Oct 1. doi: 10.1097/QAI.0000000000001877.
    PubMed     Text format     Abstract available

  31. MASSANELLA M, Karris MY, Perez-Santiago J, Yek C, et al
    Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.
    J Acquir Immune Defic Syndr. 2018;79:399-406.
    PubMed     Text format     Abstract available


    J Immunol

  32. DEL RIO-INIGUEZ I, Vazquez-Chavez E, Cuche C, Di Bartolo V, et al
    HIV-1 Nef Hijacks Lck and Rac1 Endosomal Traffic To Dually Modulate Signaling-Mediated and Actin Cytoskeleton-Mediated T Cell Functions.
    J Immunol. 2018 Oct 3. pii: jimmunol.1800372. doi: 10.4049/jimmunol.1800372.
    PubMed     Text format     Abstract available


    J Infect Dis

  33. SZANIAWSKI MA, Spivak AM, Bosque A, Planelles V, et al
    Sex influences SAMHD1 activity and susceptibility to HIV-1 in primary human macrophages.
    J Infect Dis. 2018 Oct 8. pii: 5123692. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. DOMBROWSKI JC, Baeten JM
    It's Time to Make the Time to Viral Suppression After HIV Diagnosis a Metric of HIV Care Success.
    J Infect Dis. 2018 Oct 10. pii: 5116321. doi: 10.1093.
    PubMed     Text format    

  35. XIA Q, Coeytaux K, Braunstein SL, Torian LV, et al
    Proposing a New Indicator for the National Human Immunodeficiency Virus/AIDS Strategy: Percentage of Newly Diagnosed Persons Achieving Viral Suppression Within 3 Months of Diagnosis.
    J Infect Dis. 2018 Oct 10. pii: 5116324. doi: 10.1093.
    PubMed     Text format     Abstract available

  36. JAIMES-BERNAL C, Rallon N, Benito JM, Mohamed-Balghata MO, et al
    Knock-out IFNL4 gene variant is associated with protection from sexually transmitted HIV-1 infection.
    J Infect Dis. 2018 Oct 5. pii: 5115710. doi: 10.1093.
    PubMed     Text format     Abstract available

  37. RICHARDS V
    Should we consider marijuana use in relation to physical activity and cognitive impairment in persons with HIV infection?
    J Infect Dis. 2018 Oct 5. pii: 5115716. doi: 10.1093.
    PubMed     Text format    

  38. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Reply to Suthar et al.
    J Infect Dis. 2018 Oct 11. pii: 5126520. doi: 10.1093.
    PubMed     Text format    

  39. SUTHAR AB, Coggin W, Raizes E
    Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS.
    J Infect Dis. 2018 Oct 11. pii: 5126519. doi: 10.1093.
    PubMed     Text format    

  40. RODRIGUEZ-GALLEGO E, Tarancon-Diez L, Garcia F, Del Romero J, et al
    Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite Control.
    J Infect Dis. 2018 Oct 12. pii: 5127217. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  41. KINLOCH NN, Lee GQ, Carlson JM, Jin SW, et al
    Genotypic and Mechanistic Characterization of Subtype-specific HIV Adaptation to Host Cellular Immunity.
    J Virol. 2018 Oct 10. pii: JVI.01502-18. doi: 10.1128/JVI.01502.
    PubMed     Text format     Abstract available

  42. HARGETT AA, Wei Q, Knoppova B, Hall S, et al
    Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles.
    J Virol. 2018 Oct 10. pii: JVI.01177-18. doi: 10.1128/JVI.01177.
    PubMed     Text format     Abstract available

  43. HOANG TN, Harper JL, Pino MC, Wang H, et al
    Bone marrow-derived CD4(+) T cells are depleted in SIV-infected macaques and contribute to the size of the replication competent reservoir on ART.
    J Virol. 2018 Oct 10. pii: JVI.01344-18. doi: 10.1128/JVI.01344.
    PubMed     Text format     Abstract available

  44. SOARE AY, Durham ND, Gopal R, Tweel B, et al
    P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1beta in a human tonsil explant model.
    J Virol. 2018 Oct 10. pii: JVI.01186-18. doi: 10.1128/JVI.01186.
    PubMed     Text format     Abstract available


    Lancet

  45. WEBSTER P
    PEPFAR at 15 years.
    Lancet. 2018;392:200.
    PubMed     Text format    

  46. NAKKAZI E
    Changes to dolutegravir policy in several African countries.
    Lancet. 2018;392:199.
    PubMed     Text format    


    Lancet HIV

  47. KARIM SSA
    Optimising the accuracy of HIV drug resistance assays.
    Lancet HIV. 2018 Sep 28. pii: S2352-3018(18)30211.
    PubMed     Text format    

  48. INZAULE SC, Hamers RL, Noguera-Julian M, Casadella M, et al
    Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
    Lancet HIV. 2018 Sep 28. pii: S2352-3018(18)30177.
    PubMed     Text format     Abstract available

  49. FINOCCHARIO-KESSLER S, Gautney B, Cheng A, Wexler C, et al
    Evaluation of the HIV Infant Tracking System (HITSystem) to optimise quality and efficiency of early infant diagnosis: a cluster-randomised trial in Kenya.
    Lancet HIV. 2018 Oct 8. pii: S2352-3018(18)30245.
    PubMed     Text format     Abstract available

  50. LESTER RT
    Digital health to support early infant diagnosis of HIV.
    Lancet HIV. 2018 Oct 8. pii: S2352-3018(18)30266.
    PubMed     Text format    

  51. KAVANAGH MM, Baral SD, Milanga M, Sugarman J, et al
    Biometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerations.
    Lancet HIV. 2018 Oct 5. pii: S2352-3018(18)30243.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  52. KISSINGER P, Muzny CA, Mena LA, Lillis RA, et al
    Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Lancet Infect Dis. 2018 Oct 5. pii: S1473-3099(18)30423.
    PubMed     Text format     Abstract available

  53. HUGHES G, Fifer H
    Point-of-care tests for chlamydia and gonorrhoea in Indigenous communities.
    Lancet Infect Dis. 2018;18:1054-1055.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  54. LUNA-GIERKE RE, Shouse RL, Luo Q, Frazier E, et al
    Differences in Characteristics and Clinical Outcomes Among Hispanic/Latino Men and Women Receiving HIV Medical Care - United States, 2013-2014.
    MMWR Morb Mortal Wkly Rep. 2018;67:1109-1114.
    PubMed     Text format     Abstract available


    N Engl J Med

  55. MUFTUOGLU M, Olson A, Marin D, Ahmed S, et al
    Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    N Engl J Med. 2018;379:1443-1451.
    PubMed     Text format     Abstract available

  56. ZASH R, Makhema J, Shapiro RL
    Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    N Engl J Med. 2018;379:979-981.
    PubMed     Text format    


    Nature

  57. BORDUCCHI EN, Liu J, Nkolola JP, Cadena AM, et al
    Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys.
    Nature. 2018 Oct 3. pii: 10.1038/s41586-018-0600.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  58. MADRID L, Maculuve SA, Vilajeliu A, Saez E, et al
    Maternal Carriage of Group B Streptococcus and Escherichia coli in a District Hospital in Mozambique.
    Pediatr Infect Dis J. 2018;37:1145-1153.
    PubMed     Text format     Abstract available


    PLoS Med

  59. LOELIGER KB, Meyer JP, Desai MM, Ciarleglio MM, et al
    Retention in HIV care during the 3 years following release from incarceration: A cohort study.
    PLoS Med. 2018;15:e1002667.
    PubMed     Text format     Abstract available


    PLoS One

  60. TEMIYE EO, Adeniyi OF, Fajolu IB, Ogbenna AA, et al
    Human immunodeficiency virus status in malnourished children seen at Lagos.
    PLoS One. 2018;13:e0200435.
    PubMed     Text format     Abstract available

  61. SOSA-JURADO F, Melendez-Mena D, Rosas-Murrieta NH, Guzman-Flores B, et al
    Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
    PLoS One. 2018;13:e0205356.
    PubMed     Text format     Abstract available

  62. LODIONGO DK, K Bior B, W Dumo G, S Katoro J, et al
    Field evaluation of SD BIOLINE HIV/Syphilis Duo assay among pregnant women attending routine antenatal care in Juba, South Sudan.
    PLoS One. 2018;13:e0205383.
    PubMed     Text format     Abstract available

  63. HIRASEN K, Berhanu R, Evans D, Rosen S, et al
    High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.
    PLoS One. 2018;13:e0205463.
    PubMed     Text format     Abstract available

  64. JUANBELTZ R, Martinez-Baz I, San Miguel R, Goni-Esarte S, et al
    Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients.
    PLoS One. 2018;13:e0205277.
    PubMed     Text format     Abstract available

  65. VAN GRIENSVEN F, Mock PA, Benjarattanaporn P, Premsri N, et al
    Estimating recent HIV incidence among young men who have sex with men: Reinvigorating, validating and implementing Osmond's algorithm for behavioral imputation.
    PLoS One. 2018;13:e0204793.
    PubMed     Text format     Abstract available

  66. PRICE CA, Green-Thompson L, Mammen VG, Madhi SA, et al
    Knowledge gaps among South African healthcare providers regarding the prevention of neonatal group B streptococcal disease.
    PLoS One. 2018;13:e0205157.
    PubMed     Text format     Abstract available

  67. NEUMANN MS, Plant A, Margolis AD, Borkowf CB, et al
    Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics.
    PLoS One. 2018;13:e0204599.
    PubMed     Text format     Abstract available

  68. QIN S, Clausen E, Nouraie SM, Kingsley L, et al
    Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation.
    PLoS One. 2018;13:e0205065.
    PubMed     Text format     Abstract available

  69. ARIMIDE DA, Abebe A, Kebede Y, Adugna F, et al
    HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
    PLoS One. 2018;13:e0205446.
    PubMed     Text format     Abstract available

  70. MAGOHE A, Mackenzie T, Kimario J, Lukmanji Z, et al
    Pre- and post-natal macronutrient supplementation for HIV-positive women in Tanzania: Effects on infant birth weight and HIV transmission.
    PLoS One. 2018;13:e0201038.
    PubMed     Text format     Abstract available

  71. PATTEN G, Bernheimer J, Fairlie L, Rabie H, et al
    Lamivudine monotherapy as a holding regimen for HIV-positive children.
    PLoS One. 2018;13:e0205455.
    PubMed     Text format     Abstract available

  72. COYER L, van Bilsen W, Bil J, Davidovich U, et al
    Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.
    PLoS One. 2018;13:e0205663.
    PubMed     Text format     Abstract available

  73. JUDD A, Foster C, Thompson LC, Sturgeon K, et al
    Sexual health of young people with perinatal HIV and HIV negative young people in England.
    PLoS One. 2018;13:e0205597.
    PubMed     Text format     Abstract available

  74. HURUY K, Mulu A, Liebert UG, Melanie M, et al
    HIV-1C proviral DNA for detection of drug resistance mutations.
    PLoS One. 2018;13:e0205119.
    PubMed     Text format     Abstract available

  75. LINCE-DEROCHE N, van Rensburg C, Roseleur J, Sanusi B, et al
    Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.
    PLoS One. 2018;13:e0203921.
    PubMed     Text format     Abstract available


    PLoS Pathog

  76. RAWLE DJ, Harrich D
    Toward the "unravelling" of HIV: Host cell factors involved in HIV-1 core uncoating.
    PLoS Pathog. 2018;14:e1007270.
    PubMed     Text format    

  77. CAO Y, Cartwright EK, Silvestri G, Perelson AS, et al
    CD8+ lymphocyte control of SIV infection during antiretroviral therapy.
    PLoS Pathog. 2018;14:e1007350.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  78. SHI G, Ozog S, Torbett BE, Compton AA, et al
    mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
    Proc Natl Acad Sci U S A. 2018 Oct 9. pii: 1811892115.
    PubMed     Text format     Abstract available


    Science

  79. COHEN J
    The pill exchange.
    Science. 2018;360:1174.
    PubMed     Text format    

  80. COHEN J
    The loyal opposition.
    Science. 2018;360:1175.
    PubMed     Text format    

  81. COHEN J
    Status symbol.
    Science. 2018;360:1171.
    PubMed     Text format    

  82. COHEN J
    Dark nights, bright stars.
    Science. 2018;360:1170-1175.
    PubMed     Text format    

  83. COHEN J
    The Sunshine State's dark cloud.
    Science. 2018;360:1176-1179.
    PubMed     Text format    

  84. COHEN J
    Poster couple.
    Science. 2018;360:1172.
    PubMed     Text format    


    Vaccine

  85. MUGO NR, Eckert L, Magaret AS, Cheng A, et al
    Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
    Vaccine. 2018 Oct 5. pii: S0264-410X(18)31328.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: